Co-Diagnostics, Inc. Participates in WHX Kuala Lumpur Event
Co-Diagnostics, Inc. (Nasdaq-CM: CODX), a leading molecular diagnostics company, is set to host a booth at the upcoming WHX (World Health Expo) being held at the Malaysia International Trade and Exhibition Centre (MITEC). This exciting event is scheduled for mid-July, offering an extraordinary platform for networking and showcasing innovations in healthcare technology.
About WHX Kuala Lumpur
WHX Kuala Lumpur, previously known as Asia Health/Medlab Asia, stands out as one of the most significant healthcare exhibitions in Southeast Asia. The event is anticipated to attract over 10,000 visitors from more than 54 countries, providing an excellent opportunity to connect with leaders from various sectors of the healthcare industry. Attendees will have the chance to explore the latest advancements in healthcare technology while discussing valuable insights into future trends.
Co-Diagnostics' Focus and Offerings
At WHX, Co-Diagnostics aims to raise awareness of its extensive range of PCR in vitro diagnostics tailored for infectious diseases. During the event, they will spotlight their proprietary Co-Primers technology and unveil their innovative Co-Dx PCR platform. This platform will include tests such as the Co-Dx PCR MTB test and the 8-plex Co-Dx HPV test, both of which are expected to initiate clinical evaluations in the near future.
Connecting with Attendees
Participants eager to delve deeper into Co-Diagnostics' offerings are encouraged to visit Booth L18. Company representatives will be on hand to discuss one-on-one about their groundbreaking technologies and how they are paving the way for advancements in diagnostics.
Support and Funding for Participation
Co-Diagnostics' participation in the WHX is made possible, in part, by a generous grant from World Trade Center Utah. This organization plays a crucial role in assisting local businesses in expanding their reach, penetrating international markets, and bolstering foreign investments, hence furthering job creation in the region.
About Co-Diagnostics, Inc.
Co-Diagnostics, Inc. is a Utah-based corporation specializing in the development, manufacturing, and marketing of advanced diagnostics technologies. The company utilizes cutting-edge technology to design tests that focus on the detection and analysis of nucleic acid molecules, namely DNA and RNA. In addition, Co-Diagnostics applies its unique technology to create specific tests for its Co-Dx PCR at-home and point-of-care platform, aiming to identify genetic markers relevant to various applications beyond infectious diseases.
Frequently Asked Questions
1. What is WHX Kuala Lumpur?
WHX Kuala Lumpur is a prominent healthcare exhibition in Southeast Asia, featuring global industry leaders and the latest health technology innovations.
2. What will Co-Diagnostics showcase at the event?
Co-Diagnostics will showcase its PCR diagnostics technologies, including the upcoming Co-Dx PCR platform and specific tests for infectious diseases.
3. How can attendees find Co-Diagnostics at the event?
Attendees can find Co-Diagnostics at Booth L18, where they can learn more about the company's products and technologies.
4. What support does Co-Diagnostics receive for this participation?
The company's attendance is supported by a grant from World Trade Center Utah, aimed at facilitating business expansion and international partnerships.
5. What is the main focus of Co-Diagnostics?
Co-Diagnostics focuses on developing state-of-the-art molecular diagnostics technologies for detecting and analyzing nucleic acids in various applications.
